A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand

Author： Ragupathy Rajan  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.11, 2012-11, pp. : 1051-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007

By Ragupathy Rajan  

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 386-393

Springer Publishing Company

Access to resources Recommend Favorite

Activities to promote quality use of medicines in New Zealand

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Perspective on New Zealand's Medicines Regulatory Environment

By Richardson R.   Shaw I.   Nolan S.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 17-22

Adis International

Access to resources Recommend Favorite

New Zealand Pharmacists and Pharmacist‐Only Medicines

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 282-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Access to statins broadened in New Zealand

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite